{"id":"https://openalex.org/W7223674981","doi":"https://doi.org/10.3389/frhem.2026.1969104","title":"Immune surveillance and emerging immunogenetic modifiers in CALR-mutated myeloproliferative neoplasms","display_name":"Immune surveillance and emerging immunogenetic modifiers in CALR-mutated myeloproliferative neoplasms","publication_year":2026,"publication_date":"2026-10-26","ids":{"openalex":"https://openalex.org/W7223674981","doi":"https://doi.org/10.3389/frhem.2026.1969104"},"language":"en","primary_location":{"id":"doi:10.3389/frhem.2026.1969104","doi":"https://doi.org/10.3389/frhem.2026.1969104","is_oa":true,"landing_page_url":"https://doi.org/10.3389/frhem.2026.1969104","pdf_url":"https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2026.1969104/pdf","source":{"id":"https://openalex.org/S4387283458","display_name":"Frontiers in Hematology","issn_l":"2813-3935","issn":["2813-3935"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2026.1969104/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036537826","display_name":"Velizar Stefanov Shivarov","orcid":"https://orcid.org/0000-0001-5362-7999","observed_orcids":["https://orcid.org/0000-0001-5362-7999"]},"institutions":[{"id":"https://openalex.org/I507746717","display_name":"Medical University Pleven","ror":"https://ror.org/049ztct72","country_code":"BG","type":"education","lineage":["https://openalex.org/I507746717"]}],"countries":["BG"],"is_corresponding":true,"raw_author_name":"Velizar Shivarov","raw_affiliation_strings":["Department of Clinical Hematology, St. Sophia General Hospital","Department of Experimental Research, Medical University Pleven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Hematology, St. Sophia General Hospital","institution_ids":[]},{"raw_affiliation_string":"Department of Experimental Research, Medical University Pleven","institution_ids":["https://openalex.org/I507746717"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5158262120","display_name":"Milena Ivanova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799356449","display_name":"Alexandrovska Hospital","ror":"https://ror.org/04b8y3f13","country_code":"BG","type":"healthcare","lineage":["https://openalex.org/I2799356449"]},{"id":"https://openalex.org/I30147112","display_name":"Medical University of Sofia","ror":"https://ror.org/01n9zy652","country_code":"BG","type":"education","lineage":["https://openalex.org/I30147112"]}],"countries":["BG"],"is_corresponding":false,"raw_author_name":"Milena Ivanova","raw_affiliation_strings":["Department of Clinical Immunology, Alexandrovska University Hospital, Medical University Sofia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Alexandrovska University Hospital, Medical University Sofia","institution_ids":["https://openalex.org/I2799356449","https://openalex.org/I30147112"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5036537826"],"corresponding_institution_ids":["https://openalex.org/I507746717"],"apc_list":{"value":1950,"currency":"CHF","value_usd":2353},"apc_paid":{"value":1950,"currency":"CHF","value_usd":2353},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83634922,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calr-mutation","display_name":"CALR mutation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.953000009059906},{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunosurveillance","display_name":"immune surveillance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/hla-genotypes","display_name":"HLA genotypes","score":0.6880000233650208},{"id":"https://openalex.org/keywords/antigen-processing","display_name":"antigen processing","score":0.5419999957084656},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.5289999842643738},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8510000109672546},{"id":"https://openalex.org/keywords/kir-hla-interaction","display_name":"HLA-KIR interaction","score":0.9340000152587891},{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.921999990940094},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.5109999775886536},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C47450691","wikidata":"https://www.wikidata.org/wiki/Q634510","display_name":"Calreticulin","level":3,"score":0.8011000156402588},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6689000129699707},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.5789999961853027},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5509999990463257},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4957999885082245},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.43290001153945923},{"id":"https://openalex.org/C2778713057","wikidata":"https://www.wikidata.org/wiki/Q18029261","display_name":"Thrombopoietin receptor","level":5,"score":0.42480000853538513},{"id":"https://openalex.org/C81089528","wikidata":"https://www.wikidata.org/wiki/Q5134986","display_name":"clone (Java method)","level":3,"score":0.42289999127388},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.398499995470047},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3905999958515167},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.35850000381469727},{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.3499999940395355},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.3492000102996826},{"id":"https://openalex.org/C32465701","wikidata":"https://www.wikidata.org/wiki/Q14914514","display_name":"Janus kinase 2","level":3,"score":0.3174999952316284},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.314300000667572},{"id":"https://openalex.org/C3019359096","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune surveillance","level":3,"score":0.3140999972820282},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.31119999289512634},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.30219998955726624},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30070000886917114},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2994999885559082},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.28929999470710754},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.27869999408721924},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.2752000093460083},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.27469998598098755},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.27250000834465027},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.2694000005722046},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C130361206","wikidata":"https://www.wikidata.org/wiki/Q908443","display_name":"Calnexin","level":4,"score":0.2635999917984009},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.26179999113082886},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.26170000433921814},{"id":"https://openalex.org/C2778473898","wikidata":"https://www.wikidata.org/wiki/Q2145110","display_name":"Repertoire","level":2,"score":0.2574999928474426},{"id":"https://openalex.org/C2775890610","wikidata":"https://www.wikidata.org/wiki/Q14914108","display_name":"CIITA","level":5,"score":0.25290000438690186}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/frhem.2026.1969104","doi":"https://doi.org/10.3389/frhem.2026.1969104","is_oa":true,"landing_page_url":"https://doi.org/10.3389/frhem.2026.1969104","pdf_url":"https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2026.1969104/pdf","source":{"id":"https://openalex.org/S4387283458","display_name":"Frontiers in Hematology","issn_l":"2813-3935","issn":["2813-3935"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Hematology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:5294aec1ce7e4f9c8387c7ee2bd4d8b1","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5294aec1ce7e4f9c8387c7ee2bd4d8b1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Hematology, Vol 5 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/frhem.2026.1969104","doi":"https://doi.org/10.3389/frhem.2026.1969104","is_oa":true,"landing_page_url":"https://doi.org/10.3389/frhem.2026.1969104","pdf_url":"https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2026.1969104/pdf","source":{"id":"https://openalex.org/S4387283458","display_name":"Frontiers in Hematology","issn_l":"2813-3935","issn":["2813-3935"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321843","display_name":"Bulgarian National Science Fund","ror":"https://ror.org/05eg49r29"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223674981.pdf","grobid_xml":"https://content.openalex.org/works/W7223674981.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W1681870720","https://openalex.org/W1993072636","https://openalex.org/W2006690805","https://openalex.org/W2013435992","https://openalex.org/W2016612145","https://openalex.org/W2043570079","https://openalex.org/W2049730817","https://openalex.org/W2094456737","https://openalex.org/W2097138271","https://openalex.org/W2102237050","https://openalex.org/W2121743767","https://openalex.org/W2138709799","https://openalex.org/W2142548447","https://openalex.org/W2146783950","https://openalex.org/W2149449736","https://openalex.org/W2157694607","https://openalex.org/W2162418942","https://openalex.org/W2165040076","https://openalex.org/W2167688505","https://openalex.org/W2181106711","https://openalex.org/W2230798701","https://openalex.org/W2306779733","https://openalex.org/W2344384041","https://openalex.org/W2417685891","https://openalex.org/W2731447759","https://openalex.org/W2774712455","https://openalex.org/W2788391979","https://openalex.org/W2790040007","https://openalex.org/W2793215815","https://openalex.org/W2795256310","https://openalex.org/W2884986908","https://openalex.org/W2896385413","https://openalex.org/W2908952707","https://openalex.org/W2954062012","https://openalex.org/W2976755053","https://openalex.org/W2982291252","https://openalex.org/W2988620928","https://openalex.org/W2990179403","https://openalex.org/W2990514426","https://openalex.org/W3003423609","https://openalex.org/W3005844923","https://openalex.org/W3013784317","https://openalex.org/W3025170387","https://openalex.org/W3037408501","https://openalex.org/W3040003446","https://openalex.org/W3134473205","https://openalex.org/W3167008187","https://openalex.org/W3204171974","https://openalex.org/W4205275616","https://openalex.org/W4213373081","https://openalex.org/W4223451706","https://openalex.org/W4229064167","https://openalex.org/W4237687615","https://openalex.org/W4281913860","https://openalex.org/W4282914934","https://openalex.org/W4283271244","https://openalex.org/W4283716970","https://openalex.org/W4296998035","https://openalex.org/W4308702374","https://openalex.org/W4318046448","https://openalex.org/W4319262239","https://openalex.org/W4362452808","https://openalex.org/W4385660700","https://openalex.org/W4385996486","https://openalex.org/W4399728606","https://openalex.org/W4402808679","https://openalex.org/W4411721635","https://openalex.org/W7123926348","https://openalex.org/W7124197506","https://openalex.org/W7165796251","https://openalex.org/W7166590568","https://openalex.org/W7167699283","https://openalex.org/W7204091421"],"related_works":["https://openalex.org/W2783959528","https://openalex.org/W2911491010","https://openalex.org/W7203660746","https://openalex.org/W4408995671","https://openalex.org/W7124197506","https://openalex.org/W3208650504","https://openalex.org/W2996425737","https://openalex.org/W2954062012","https://openalex.org/W3003967832","https://openalex.org/W2908952707"],"abstract_inverted_index":{"Calreticulin":[0],"(":[1],"CALR":[2,24,62,82,188],")":[3],"exon":[4],"9":[5],"mutations":[6,63],"define":[7],"a":[8,38,238],"major":[9],"molecular":[10],"subgroup":[11],"of":[12,120,233,258],"essential":[13],"thrombocythemia":[14],"and":[15,25,86,93,113,148,164,178,181,199,219,247,263],"primary":[16],"myelofibrosis.":[17],"Although":[18],"the":[19,26,33,76,118,161,255],"oncogenic":[20,242],"interaction":[21],"between":[22],"mutant":[23,81,121],"thrombopoietin":[27],"receptor":[28],"MPL":[29],"is":[30,44,96,158],"well":[31],"established,":[32],"factors":[34],"that":[35,80,124],"influence":[36,117],"whether":[37],"newly":[39],"arising":[40],"CALR-mutant":[41,259],"hematopoietic":[42],"clone":[43],"eliminated,":[45],"contained,":[46],"or":[47,139,190,225],"allowed":[48],"to":[49,99,107,129,185,187,254],"expand":[50],"remain":[51,197],"incompletely":[52],"understood.":[53],"The":[54],"shared":[55],"neomorphic":[56],"C-terminal":[57],"sequence":[58],"generated":[59],"by":[60,160,165],"pathogenic":[61],"creates":[64],"an":[65],"unusual":[66],"model":[67,239],"for":[68],"studying":[69],"driver-specific":[70],"cancer":[71],"immunoediting.":[72],"Evidence":[73],"accumulated":[74],"over":[75],"past":[77],"decade":[78],"indicates":[79],"can":[83,125,272],"elicit":[84],"CD4+":[85],"CD8+":[87],"T-cell":[88],"responses,":[89],"yet":[90],"naturally":[91],"occurring":[92],"vaccine-induced":[94],"immunity":[95],"frequently":[97],"insufficient":[98],"control":[100],"disease.":[101],"Host":[102],"immunogenetic":[103,270],"variation":[104],"may":[105,251],"contribute":[106,253],"this":[108],"discrepancy.":[109],"HLA":[110,173],"class":[111,114],"I":[112],"II":[115],"genotypes":[116],"repertoire":[119],"CALR-derived":[122],"peptides":[123],"be":[126,273],"stably":[127],"presented":[128],"T":[130],"cells,":[131],"whereas":[132],"antigen":[133],"processing":[134],"additionally":[135],"depends":[136],"on":[137],"proteasomal":[138],"endosomal":[140],"cleavage,":[141],"TAP":[142],"transport,":[143],"peptide-loading":[144],"machinery,":[145],"source-protein":[146],"abundance,":[147],"other":[149,216,223],"cellular":[150],"factors.":[151],"In":[152],"parallel,":[153],"natural":[154],"killer":[155],"cell":[156],"surveillance":[157],"influenced":[159],"NKG2D-MICA/MICB":[162],"axis":[163],"inhibitory":[166],"KIR-HLA":[167],"interactions.":[168],"Recent":[169],"studies":[170,266],"have":[171,200],"linked":[172],"genotypes,":[174],"MICA":[175],"/":[176],"MICB":[177],"KLRK1":[179],"variation,":[180],"KIR":[182],"receptor-ligand":[183],"combinations":[184],"susceptibility":[186],"-mutated":[189],"related":[191],"myeloproliferative":[192],"neoplasms,":[193],"although":[194],"most":[195],"observations":[196],"exploratory":[198],"not":[201],"been":[202],"independently":[203],"replicated.":[204],"This":[205],"review":[206],"integrates":[207],"direct":[208],"CALR-mutated":[209],"MPN":[210,217],"evidence":[211,214,221],"with":[212],"comparative":[213],"from":[215,222],"subtypes":[218],"mechanistic":[220],"malignancies":[224],"experimental":[226],"systems,":[227],"while":[228],"explicitly":[229],"distinguishing":[230],"their":[231],"levels":[232],"support.":[234],"Current":[235],"data":[236],"support":[237],"in":[240],"which":[241],"signaling,":[243],"inherited":[244],"immune-recognition":[245],"capacity,":[246],"acquired":[248],"immune":[249],"escape":[250],"jointly":[252],"evolutionary":[256],"trajectory":[257],"clones.":[260],"Multicenter,":[261],"ancestry-matched":[262],"functionally":[264],"integrated":[265],"are":[267],"required":[268],"before":[269],"markers":[271],"translated":[274],"into":[275],"clinical":[276],"practice.":[277]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-27T00:00:00"}